CStone Pharmaceuticals
CSPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $4,773,858 | $2,106,260 | $1,299,656 | $2,903,291 |
| - Cash | $457,766 | $387,937 | $678,856 | $996,671 |
| + Debt | $391,373 | $355,973 | $334,668 | $363,448 |
| Enterprise Value | $4,707,465 | $2,074,296 | $955,468 | $2,270,068 |
| Revenue | $24,726 | $153,040 | $254,165 | $202,368 |
| % Growth | -83.8% | -39.8% | 25.6% | – |
| Gross Profit | -$46,395 | $68,125 | $172,029 | $150,858 |
| % Margin | -187.6% | 44.5% | 67.7% | 74.5% |
| EBITDA | -$133,103 | -$85,282 | $3,222 | -$342,381 |
| % Margin | -538.3% | -55.7% | 1.3% | -169.2% |
| Net Income | -$135,092 | -$106,906 | $15,699 | -$158,008 |
| % Margin | -546.4% | -69.9% | 6.2% | -78.1% |
| EPS Diluted | -0.1 | -0.084 | 0.012 | -0.124 |
| % Growth | -19.3% | -775.8% | 110% | – |
| Operating Cash Flow | $0 | -$156,049 | -$187,132 | -$248,016 |
| Capital Expenditures | $0 | $0 | $0 | -$15 |
| Free Cash Flow | $0 | -$156,049 | -$187,132 | -$248,031 |